Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues $ 0 $ 0
Costs and expenses    
Operating expenses 200,000 214,000
Research and development expenses 48,000 47,000
Loss from operations (248,000) (261,000)
Other income (expense)    
Gain on partial forgiveness of PPP note payable 24,000 0
Interest and financing expense (77,000) (110,000)
Net Loss $ (301,000) $ (371,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00)
Weighted average common shares outstanding, basic and diluted 355,742,036 323,167,576